Clinical Trials Browser

Phase 1/2 × OTHER × Ethiodized Oil × Clear all

NCT02638857 2016-01-01

Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma

Phase 1/2 Unknown

Gastrointestinal

Recurrence Hepatocellular Carcinoma